Paz J. Vellanki

460 citations
13 papers · 254 indexed · h-index 7
Topics
Cancer Immunotherapy and Biomarkers (6 papers)Lung Cancer Treatments and Mutations (6 papers)Colorectal Cancer Treatments and Studies (4 papers)

In The Last Decade

Paz J. Vellanki

12 papers receiving 251 citations

Peers

Paz J. Vellanki
Comparison fields: 5 of 44
  • Oncology 160
  • Pulmonary and Respiratory Medicine 115
  • Molecular Biology 57
  • Cancer Research 54
  • Immunology 41
Replace Guzmán Alonso with:
Guzmán Alonso Spain
Denise Lau United States
Dezuo Dong China
Jiebai Zhou China
Ying Cheng China
Denisse Bretel Peru
Giulia Grizzi Italy
Johan M. van Rooijen Netherlands
Xia Zhou China
Zhongmin Maxwell Wang Australia
Paz J. Vellanki relative to Guzmán Alonso Spain Guzmán Alonso's profile →
Citations per field
00.5×1.5×
Guzmán Alonso · 1×
Citations per year

Countries citing papers authored by Paz J. Vellanki

Since Specialization
Citations

This map shows the geographic impact of Paz J. Vellanki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paz J. Vellanki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paz J. Vellanki more than expected).

Fields of papers citing papers by Paz J. Vellanki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paz J. Vellanki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paz J. Vellanki. The network helps show where Paz J. Vellanki may publish in the future.

Co-authorship network of co-authors of Paz J. Vellanki

This figure shows the co-authorship network connecting the top 25 collaborators of Paz J. Vellanki. A scholar is included among the top collaborators of Paz J. Vellanki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paz J. Vellanki. Paz J. Vellanki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 0
2 10
3 4
4 4
5 36
6 30
7 37
8 42
9 5
10 41
11 6
12 38
13 1

About Paz J. Vellanki

Paz J. Vellanki is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 13 papers that have together received 254 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Colorectal Cancer Treatments and Studies (4 papers). The work is most often cited by research in Oncology (160 citations), Cancer Research (54 citations) and Pulmonary and Respiratory Medicine (115 citations). Paz J. Vellanki has collaborated with scholars based in United States, Singapore and Canada. Frequent co-authors include Richard Pazdur, Harpreet Singh, Julia A. Beaver, Shenghui Tang, Pallavi S. Mishra‐Kalyani, Nicole Drezner, Michael Fusco, Anand Pathak, Dianne Spillman and Qiuyi Choo. Their work appears in journals such as Journal of Clinical Oncology, Cancer Cell and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026